Page last updated: 2024-11-06

estriol and Aneuploid

estriol has been researched along with Aneuploid in 21 studies

hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.

Research Excerpts

ExcerptRelevanceReference
"To assess the value of alpha-fetoprotein (AFP), total human chorionic gonadotropin (ThCG) and unconjugated estriol in predicting certain complications of pregnancy other than fetal aneuploidy."7.72Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. ( Duric, K; Kalafatic, D; Kuvacic, I; Lesin, J; Skrablin, S; Suchanek, E, 2003)
" To evaluate the efficacy of screening for detection of aneuploid pregnancy in this age group, the serum samples of 34 women who underwent amniocentesis and who had confirmed fetal aneuploidy were assayed for alpha-fetoprotein (AFP), hCG, and unconjugated estriol (E3)."7.68Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol. ( Canick, JA; Heyl, PS; Miller, W, 1990)
"To determine the association between second-trimester serum Down syndrome screening (alpha-fetoprotein [AFP] free beta-human chorionic gonadotropin [b-hCG] unconjugated estriol [uE3]) and preterm birth and to create predictive models for preterm birth."3.91Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study. ( Luewan, S; Nunthapiwat, S; Sekararithi, R; Sirichotiyakul, S; Srisupundit, K; Tongprasert, F; Tongsong, T; Wanapirak, C, 2019)
"Our study suggest that in patients with hereditary thrombophilia a new correction factor should be used, when calculating unconjugated estriol MoM value, which is one of the markers of second trimester aneuploidy screening test."3.81The effect of inherited thrombophilia on second trimester combined aneuploidy screening test markers. ( Baser, E; Cicek, MN; Cıkman, DI; Cıkman, MS; Karslı, MF; Seckin, KD, 2015)
"To evaluate if levels of pregnancy-associated plasma protein-A (PAPP-A), free β-hCG and nuchal translucency (NT) used in first trimester aneuploidy screening and α-fetoprotein (AFP), unconjugated oestriol (UE3) and free β-hCG in the second trimester are altered in pregnancies with human immunodeficiency virus (HIV) infection."3.77First and second trimester markers of fetal aneuploidy in pregnant women with HIV infection. ( Spencer, K, 2011)
" All patients had a first-trimester nuchal translucency scan, and those without cystic hygroma had a combined test (nuchal translucency, pregnancy-associated plasma protein A, and free beta-hCG) and returned at 15-18 weeks for a second-trimester quadruple screen (serum alpha-fetoprotein, total hCG, unconjugated estriol, and inhibin-A)."3.74First- and second-trimester screening: detection of aneuploidies other than Down syndrome. ( Berkowitz, RL; Bianchi, DW; Breathnach, FM; Carr, SR; Comstock, CH; Craigo, SD; Cuckle, HS; D'Alton, ME; Dugoff, L; Klugman, S; Lambert-Messerlian, G; Malone, FD; Nyberg, DA; Porter, TF; Saade, GR; Timor-Tritsch, IE; Tripp, T; Wolfe, HM, 2007)
"To assess the value of alpha-fetoprotein (AFP), total human chorionic gonadotropin (ThCG) and unconjugated estriol in predicting certain complications of pregnancy other than fetal aneuploidy."3.72Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. ( Duric, K; Kalafatic, D; Kuvacic, I; Lesin, J; Skrablin, S; Suchanek, E, 2003)
"to review the contribution of unconjugated estriol in Down's syndrome detection, and influence of maternal age, cut-off choice, and population specificity on the balance between triple-marker test sensitivity and specificity."3.70The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity. ( Huderer-Duric, K; Kuvacic, I; Rubala, D; Skrablin, S; Sonicki, Z; Suchanek, E, 2000)
"Data from 24,504 patients who had biochemical screening for Down syndrome by single (alpha-fetoprotein), double (alpha-fetoprotein, beta-human chorionic gonadotropin), or triple screening (alpha-fetoprotein, beta-human chorionic gonadotropin, unconjugated estriol) who had complete outcome information were analyzed by (1) existing gaussian-based methods, (2) the Glasgow ratio method, and (3) a new statistical approach (i."3.69MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs. ( Ager, JW; Ayoub, M; Chik, L; Chin, B; Dvorin, E; Evans, MI; Johnson, MP; Krivchenia, EL; O'Brien, JE; Sokol, RJ, 1995)
"A retrospective evaluation of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated oestriol (uE3) levels in maternal blood in the second trimester was conducted for cases of aneuploid pregnancies identified from a series of women who underwent amniocentesis."3.69A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy. ( Murakami, I; Natori, M; Okada, S; Sato, A; Suzumori, K; Takagi, T; Tanaka, M; Tanemura, M, 1997)
" To evaluate the efficacy of screening for detection of aneuploid pregnancy in this age group, the serum samples of 34 women who underwent amniocentesis and who had confirmed fetal aneuploidy were assayed for alpha-fetoprotein (AFP), hCG, and unconjugated estriol (E3)."3.68Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol. ( Canick, JA; Heyl, PS; Miller, W, 1990)
"Although the risk for fetal aneuploidy is not altered by obesity, the risk for significant birth defects is increased."2.53Genetic Screening and the Obese Gravida. ( Rose, NC, 2016)
"Missed aneuploidies included trisomy 21, sex chromosome abnormalities, trisomy 13, trisomy 22, and trisomy 18."1.29Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old. ( Boots, L; Desai, R; DuBard, MB; Owen, J; Wenstrom, KD, 1995)
"For the detection of one infant with trisomy 18 that will survive past five months, 25 normal fetuses would be lost owing to amniocentesis."1.29Prenatal sonographic detection of isolated fetal choroid plexus cysts: should we screen for trisomy 18? ( Donnenfeld, AE, 1995)

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (28.57)18.2507
2000's5 (23.81)29.6817
2010's9 (42.86)24.3611
2020's1 (4.76)2.80

Authors

AuthorsStudies
Pierre, CC1
Greene, DN1
Delaney, S1
Lockwood, CM1
Peck Palmer, OM1
Yamashiro, KJ1
Galganski, LA1
Hirose, S1
Quibel, T1
Rozenberg, P1
Nunthapiwat, S1
Sekararithi, R1
Wanapirak, C1
Sirichotiyakul, S1
Tongprasert, F1
Srisupundit, K1
Luewan, S1
Tongsong, T1
Chasen, ST1
Cıkman, MS1
Seckin, KD1
Karslı, MF1
Baser, E1
Cıkman, DI1
Cicek, MN1
Rose, NC1
Pekarek, DM1
Chapman, VR1
Neely, CL1
Ramsey, PS1
Biggio, JR1
Dugoff, L2
Spencer, K1
Hui, D1
Okun, N1
Murphy, K1
Kingdom, J1
Uleryk, E1
Shah, PS1
Duric, K1
Skrablin, S2
Lesin, J1
Kalafatic, D1
Kuvacic, I2
Suchanek, E2
Summers, AM1
Farrell, SA1
Huang, T1
Meier, C1
Wyatt, PR1
Breathnach, FM1
Malone, FD1
Lambert-Messerlian, G1
Cuckle, HS1
Porter, TF1
Nyberg, DA1
Comstock, CH1
Saade, GR1
Berkowitz, RL1
Klugman, S1
Craigo, SD1
Timor-Tritsch, IE1
Carr, SR1
Wolfe, HM1
Tripp, T1
Bianchi, DW1
D'Alton, ME1
Wenstrom, KD2
Desai, R1
Owen, J2
DuBard, MB1
Boots, L2
Donnenfeld, AE1
Evans, MI1
Chik, L1
O'Brien, JE1
Chin, B1
Dvorin, E1
Ayoub, M1
Krivchenia, EL1
Ager, JW1
Johnson, MP1
Sokol, RJ1
Suzumori, K1
Tanemura, M1
Murakami, I1
Okada, S1
Natori, M1
Tanaka, M1
Takagi, T1
Sato, A1
Chu, Dc1
Huderer-Duric, K1
Sonicki, Z1
Rubala, D1
Heyl, PS1
Miller, W1
Canick, JA1

Reviews

4 reviews available for estriol and Aneuploid

ArticleYear
What you need to know about maternal-fetal medicine.
    Seminars in pediatric surgery, 2019, Volume: 28, Issue:4

    Topics: alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Congenital Abnormalities; Estriol; Female; F

2019
Maternal serum analyte screening for fetal aneuploidy.
    Clinical obstetrics and gynecology, 2014, Volume: 57, Issue:1

    Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Chromosome

2014
Genetic Screening and the Obese Gravida.
    Clinical obstetrics and gynecology, 2016, Volume: 59, Issue:1

    Topics: alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Chromosome Disorders; Congenital Abnormaliti

2016
Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2012, Volume: 34, Issue:2

    Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Estriol; Female; Gestational Age

2012

Other Studies

17 other studies available for estriol and Aneuploid

ArticleYear
Reconsidering the use of race adjustments in maternal serum screening.
    American journal of obstetrics and gynecology, 2023, Volume: 229, Issue:5

    Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Sub

2023
[What are the real purpose and scope of screening for aneuploidy?]
    Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:2

    Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; DNA; Down S

2018
Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study.
    Gynecologic and obstetric investigation, 2019, Volume: 84, Issue:4

    Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Down

2019
The effect of inherited thrombophilia on second trimester combined aneuploidy screening test markers.
    Archives of gynecology and obstetrics, 2015, Volume: 291, Issue:4

    Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Case-Control Studies; Chorionic Gonadotropin; Est

2015
Medication effects on midtrimester maternal serum screening.
    American journal of obstetrics and gynecology, 2009, Volume: 201, Issue:6

    Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chromosome Disorders; Coh

2009
First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes.
    Obstetrics and gynecology, 2010, Volume: 115, Issue:5

    Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Estriol; Female; Fetal Gr

2010
First and second trimester markers of fetal aneuploidy in pregnant women with HIV infection.
    Fetal diagnosis and therapy, 2011, Volume: 29, Issue:2

    Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Case-Control Studies; Chorionic Gonadotropin, bet

2011
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
    European journal of obstetrics, gynecology, and reproductive biology, 2003, Sep-10, Volume: 110, Issue:1

    Topics: Abortion, Spontaneous; Adult; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Down Syndrome;

2003
Maternal serum screening in Ontario using the triple marker test.
    Journal of medical screening, 2003, Volume: 10, Issue:3

    Topics: alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chromosomes, Huma

2003
First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Obstetrics and gynecology, 2007, Volume: 110, Issue:3

    Topics: Adult; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin, beta Subunit, Human; Diagnosis, Diffe

2007
Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old.
    American journal of obstetrics and gynecology, 1995, Volume: 173, Issue:4

    Topics: Adult; alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chromosome

1995
Prenatal sonographic detection of isolated fetal choroid plexus cysts: should we screen for trisomy 18?
    Journal of medical screening, 1995, Volume: 2, Issue:1

    Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Brain Diseases; Chorionic Gonadotropin; Choroid Plexus;

1995
MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs.
    American journal of obstetrics and gynecology, 1995, Volume: 172, Issue:4 Pt 1

    Topics: Adolescent; Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chorionic Gon

1995
A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Prenatal diagnosis, 1997, Volume: 17, Issue:9

    Topics: Adult; Algorithms; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Chromosomes, Human, Pair

1997
Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
    American journal of obstetrics and gynecology, 1999, Volume: 181, Issue:4

    Topics: alpha-Fetoproteins; Amniocentesis; Aneuploidy; Chorionic Gonadotropin; Chorionic Gonadotropin, beta

1999
The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
    European journal of obstetrics, gynecology, and reproductive biology, 2000, Volume: 88, Issue:1

    Topics: Adult; Age Factors; alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropi

2000
Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
    Obstetrics and gynecology, 1990, Volume: 76, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Down Syndrom

1990
chemdatabank.com